Dose tolerance study fluticasone propionate aqueous nasal spray patients seasonal allergic rhinitis multicenter double-blind parallel-group dose-tolerance study safety fluticasone propionate aqueous nasal spray potent new corticosteroid preparation Ninety-seven adult patients moderate severe seasonal allergic rhinitis fall weed season placebo fluticasone propionate doses micrograms weeks Safety evaluations adrenal function evaluation morning plasma cortisol concentration response ACTH stimulation urinary free cortisol excretion evidence effects adrenal function dose severity nature frequency adverse events similar treatment groups placebo Drug-related adverse events consistent local nasal irritation groups fluticasone propionate improvement nasal symptoms obstruction rhinorrhea sneezing placebo group results fluticasone aqueous nasal spray safe micrograms day effective treatment seasonal allergic rhinitis 